| 1. |
Mino JS, Monteiro R, Pigalarga R, et al. Diffuse malignant epithelioid mesothelioma in a bacground of benign multicystic peritonealmesothelioma: a case report and review of the literature. BMJ Case Rep, 2014: bcr201300212.
|
| 2. |
Beebe-Dimmer JL, Fryzek JP, Yee CL, et al. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol, 2016, 8: 743-750.
|
| 3. |
Guo G, Chmielecki J, Goparaju C, et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res, 2015, 75(2): 264-269.
|
| 4. |
黃淵金, 廖錦堂, 肖螢, 等. 超聲引導下自動活檢對腹膜病變的診斷價值. 湖南醫科大學學報, 2001, 26(1): 69-72.
|
| 5. |
Kato K, Gemba K, Fujimoto N, et al. Computed tomographic features of malignant peritonal mesothelioma. Anticancer Res, 2016, 36(3): 1067-1072.
|
| 6. |
王慧芳, 曾獻軍, 何來昌, 等. 惡性腹膜間皮瘤 CT 表現(附 9 例報告并文獻復習). 實用放射學雜志, 2016, 32(7): 1147-1149.
|
| 7. |
曾艷, 童瑞, 王翔耀, 等. 惡性腹膜間皮瘤 26 例臨床特點及預后影響因素分析. 解放軍醫學院學報, 2015(6): 559-562.
|
| 8. |
Alexander HR Jr, Burke AP. Diagnosis and management of patients with malignant peritneal mesothelioma. J Gastrointest Oncol, 2016, 7(1): 79-86.
|
| 9. |
Foster JM, Radhakrishna U, Govindarajan V, et al. Predictive value of novel and existing activating EGFR mutations for improved survival in malignant peritonal mesothelioma (MPM) and response to EGFR-TK inhibitors (EGFR-TKI). J Clin Oncol, 2009, 27(Suppl15): 11030.
|
| 10. |
Loharamtaweethong K, Puripat N, Aoonjai N, et al. Anaplastic lymphoma kinase ( ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum. Histopathology, 2016, 68(4): 603-607.
|
